stars 1 stars 2 stars 3

Founded in 2017, TissueAegis is a company developing an innovative medical device for the storage, transport and quality control of human tissue grafts. TissueAegis is the result of several years of R&D in a public research laboratory in France. Our novel approach is a breakthrough innovation: The medical device is a potential “Game Changer” consisting on a single-use closed system capable of both preserving and transporting human transplants, while allowing monitoring and controlling key parameters. NanoC-kit is our first truly innovative medical device dedicated to corneal grafts. It is based on a smart combination of cutting-edge nanotechnology systems all integrated within a closed system. The originality lies in the association of an optical metrology device, with nano-sensors around and inside a closed biocompatible chamber.

TissueAegis Questions

The TissueAegis annual revenue was $4 million in 2026.

TissueAegis is based in Dijon, Bourgogne-Franche-Comté.

The NAICS codes for TissueAegis are [54, 541713, 5417, 54171, 541].

The SIC codes for TissueAegis are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users